Table 1

Baseline clinical characteristics of subjects

Combined (ERT and controls), n = 57ERT, n = 29Controls, n = 28p Value
All values are mean (SD).
*Values are the number of subjects in each grade. Fisher’s exact test was used to test for differences between groups.
BMI, body mass index; ERT, oestrogen replacement therapy; SF-36, short form 36 item general health questionnaire; WOMAC, Western Ontario and Mc Master Universities osteoarthritis index.
Age (years)57 (5.9)58 (6.0)56 (5.8)0.20
Height (m)1.64 (0.07)1.65 (0.08)1.63 (0.07)0.57
Weight (kg)70.0 (13.6)69.0 (11.0)70.9 (15.9)0.60
BMI (kg/m2)26 (5.1)25.5 (4.0)26.6 (6.0)0.42
WOMAC, pain dimension2.1 (3.1)2.3 (3.6)1.9 (2.5)0.62
Physical function (SF-36)51.2 (6.7)50.5 (7.6)52.0 (5.7)0.39
Mental health function (SF-36)51.1 (8.0)50.1 (8.2)52.1 (7.8)0.35
Exercise level7.4 (1.7)7.5 (1.5)7.4 (1.9)0.73
Radiological osteoarthritis*
Maximum grade of osteophyte
    05329240.05
    133
    211
Maximum grade of joint space narrowing
    04525200.17
    11248
Medial tibial cartilage volume (ml)1.53 (0.31)1.56 (0.29)1.49 (0.33)0.41
Lateral tibial cartilage volume (ml)1.99 (0.38)2.00 (0.37)1.97 (0.40)0.76
Medial tibial area (μm2)1670 (200)1660 (183)1673 (230)0.80
Lateral tibial area (μm2)1060 (140)1044 (142)1074 (132)0.42
Time between scans (years)2.5 (0.16)2.5 (0.15)2.5 (0.16)0.32